Structure Therapeutics Inc. (NASDAQ:GPCR) is one of the best small cap stocks with biggest upside potential. On August 7, ...

The vaccine would train the immune system to fight cancer-causing mutations, according to new research from UCLA Health.

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

While smoking rates in the United States have substantially declined over the past six decades, smoking remains high among ...

Aclaris Therapeutics Inc. (NASDAQ: ACRS) is one of the most promising penny stocks under $5. On July 29, Aclaris Therapeutics ...

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

Government seeks to bring down barriers, but issues such as difficulty in sourcing patients' full medical records remain Hong ...

Chapel Hill-based University of North Carolina Lineberger Comprehensive Cancer Center has been awarded up to $28 million to develop an adaptive clinical trial targeting metastatic breast cancer.  The ...

As part of workforce reductions, Protagenic is terminating Barrett Evans as chief executive and Colin Stott as chief operating officer. Evans and Stott remain on the board of directors.